List of Tables
Table 1. Global GLP-1 Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global GLP-1 Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global GLP-1 Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global GLP-1 Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global GLP-1 Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global GLP-1 Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global GLP-1 Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market GLP-1 Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of GLP-1 Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of GLP-1 Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of GLP-1 Injection, Product Types and Applications
Table 12. Global Key Manufacturers of GLP-1 Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP-1 Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on GLP-1 Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP-1 Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global GLP-1 Injection Sales by Region (K Units), 2021–2026
Table 18. Global GLP-1 Injection Sales Market Share by Region (2021–2026)
Table 19. Global GLP-1 Injection Sales by Region (K Units), 2027–2032
Table 20. Global GLP-1 Injection Sales Market Share by Region (2027–2032)
Table 21. Global GLP-1 Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global GLP-1 Injection Revenue Market Share by Region (2021–2026)
Table 23. Global GLP-1 Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global GLP-1 Injection Revenue Market Share by Region (2027–2032)
Table 25. North America GLP-1 Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America GLP-1 Injection Sales by Country (K Units), 2021–2026
Table 27. North America GLP-1 Injection Sales by Country (K Units), 2027–2032
Table 28. North America GLP-1 Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America GLP-1 Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe GLP-1 Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe GLP-1 Injection Sales by Country (K Units), 2021–2026
Table 32. Europe GLP-1 Injection Sales by Country (K Units), 2027–2032
Table 33. Europe GLP-1 Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe GLP-1 Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific GLP-1 Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific GLP-1 Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific GLP-1 Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific GLP-1 Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific GLP-1 Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America GLP-1 Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America GLP-1 Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America GLP-1 Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America GLP-1 Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America GLP-1 Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa GLP-1 Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa GLP-1 Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa GLP-1 Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa GLP-1 Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa GLP-1 Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global GLP-1 Injection Sales (K Units) by Type (2021–2026)
Table 51. Global GLP-1 Injection Sales (K Units) by Type (2027–2032)
Table 52. Global GLP-1 Injection Sales Market Share by Type (2021–2026)
Table 53. Global GLP-1 Injection Sales Market Share by Type (2027–2032)
Table 54. Global GLP-1 Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global GLP-1 Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global GLP-1 Injection Revenue Market Share by Type (2021–2026)
Table 57. Global GLP-1 Injection Revenue Market Share by Type (2027–2032)
Table 58. Global GLP-1 Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global GLP-1 Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global GLP-1 Injection Sales (K Units) by Application (2021–2026)
Table 61. Global GLP-1 Injection Sales (K Units) by Application (2027–2032)
Table 62. Global GLP-1 Injection Sales Market Share by Application (2021–2026)
Table 63. Global GLP-1 Injection Sales Market Share by Application (2027–2032)
Table 64. Global GLP-1 Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global GLP-1 Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global GLP-1 Injection Revenue Market Share by Application (2021–2026)
Table 67. Global GLP-1 Injection Revenue Market Share by Application (2027–2032)
Table 68. Global GLP-1 Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global GLP-1 Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novo Nordisk GLP-1 Injection Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly GLP-1 Injection Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Huadong Medicine Company Information
Table 81. Huadong Medicine Description and Business Overview
Table 82. Huadong Medicine GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Huadong Medicine GLP-1 Injection Product
Table 84. Huadong Medicine Recent Developments/Updates
Table 85. Innovent Biologics Company Information
Table 86. Innovent Biologics Description and Business Overview
Table 87. Innovent Biologics GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Innovent Biologics GLP-1 Injection Product
Table 89. Innovent Biologics Recent Developments/Updates
Table 90. Hengrui Medicine Company Information
Table 91. Hengrui Medicine Description and Business Overview
Table 92. Hengrui Medicine GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hengrui Medicine GLP-1 Injection Product
Table 94. Hengrui Medicine Recent Developments/Updates
Table 95. Borui Pharmaceuticals Company Information
Table 96. Borui Pharmaceuticals Description and Business Overview
Table 97. Borui Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Borui Pharmaceuticals GLP-1 Injection Product
Table 99. Borui Pharmaceuticals Recent Developments/Updates
Table 100. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
Table 101. Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
Table 102. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product
Table 104. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
Table 105. CSPC Pharmaceutical Group Company Information
Table 106. CSPC Pharmaceutical Group Description and Business Overview
Table 107. CSPC Pharmaceutical Group GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CSPC Pharmaceutical Group GLP-1 Injection Product
Table 109. CSPC Pharmaceutical Group Recent Developments/Updates
Table 110. Hansoh Pharmaceuticals Company Information
Table 111. Hansoh Pharmaceuticals Description and Business Overview
Table 112. Hansoh Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Hansoh Pharmaceuticals GLP-1 Injection Product
Table 114. Hansoh Pharmaceuticals Recent Developments/Updates
Table 115. Gan & Lee Pharmaceuticals Company Information
Table 116. Gan & Lee Pharmaceuticals Description and Business Overview
Table 117. Gan & Lee Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Gan & Lee Pharmaceuticals GLP-1 Injection Product
Table 119. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 120. Sihuan Pharmaceuticals Company Information
Table 121. Sihuan Pharmaceuticals Description and Business Overview
Table 122. Sihuan Pharmaceuticals GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sihuan Pharmaceuticals GLP-1 Injection Product
Table 124. Sihuan Pharmaceuticals Recent Developments/Updates
Table 125. Wanbang Biopharma Company Information
Table 126. Wanbang Biopharma Description and Business Overview
Table 127. Wanbang Biopharma GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Wanbang Biopharma GLP-1 Injection Product
Table 129. Wanbang Biopharma Recent Developments/Updates
Table 130. Imeik Company Information
Table 131. Imeik Description and Business Overview
Table 132. Imeik GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Imeik GLP-1 Injection Product
Table 134. Imeik Recent Developments/Updates
Table 135. Zhengda Tianqing Company Information
Table 136. Zhengda Tianqing Description and Business Overview
Table 137. Zhengda Tianqing GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Zhengda Tianqing GLP-1 Injection Product
Table 139. Zhengda Tianqing Recent Developments/Updates
Table 140. Hongyun Huaning Company Information
Table 141. Hongyun Huaning Description and Business Overview
Table 142. Hongyun Huaning GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Hongyun Huaning GLP-1 Injection Product
Table 144. Hongyun Huaning Recent Developments/Updates
Table 145. Pegbio Company Information
Table 146. Pegbio Description and Business Overview
Table 147. Pegbio GLP-1 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Pegbio GLP-1 Injection Product
Table 149. Pegbio Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. GLP-1 Injection Distributors List
Table 153. GLP-1 Injection Customers List
Table 154. GLP-1 Injection Market Trends
Table 155. GLP-1 Injection Market Drivers
Table 156. GLP-1 Injection Market Challenges
Table 157. GLP-1 Injection Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Injection
Figure 2. Global GLP-1 Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global GLP-1 Injection Market Share by Type: 2025 & 2032
Figure 4. Liraglutide Product Picture
Figure 5. Semaglutide Product Picture
Figure 6. Tirzepatide Product Picture
Figure 7. Benaglutide Product Picture
Figure 8. Others Product Picture
Figure 9. Global GLP-1 Injection Market Value by Application (US$ Million), 2021–2032
Figure 10. Global GLP-1 Injection Market Share by Application: 2025 & 2032
Figure 11. Diabetes
Figure 12. Obesity
Figure 13. Others
Figure 14. Global GLP-1 Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global GLP-1 Injection Market Size (US$ Million), 2021–2032
Figure 16. Global GLP-1 Injection Sales (K Units), 2021–2032
Figure 17. Global GLP-1 Injection Average Price (US$/Unit), 2021–2032
Figure 18. GLP-1 Injection Report Years Considered
Figure 19. GLP-1 Injection Sales Share by Manufacturers in 2025
Figure 20. Global GLP-1 Injection Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global GLP-1 Injection Players: Market Share by Revenue in GLP-1 Injection in 2025
Figure 22. GLP-1 Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global GLP-1 Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America GLP-1 Injection Sales Market Share by Country (2021–2032)
Figure 25. North America GLP-1 Injection Revenue Market Share by Country (2021–2032)
Figure 26. United States GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe GLP-1 Injection Sales Market Share by Country (2021–2032)
Figure 29. Europe GLP-1 Injection Revenue Market Share by Country (2021–2032)
Figure 30. Germany GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific GLP-1 Injection Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific GLP-1 Injection Revenue Market Share by Region (2021–2032)
Figure 37. China GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America GLP-1 Injection Sales Market Share by Country (2021–2032)
Figure 45. Latin America GLP-1 Injection Revenue Market Share by Country (2021–2032)
Figure 46. Mexico GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa GLP-1 Injection Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa GLP-1 Injection Revenue Market Share by Country (2021–2032)
Figure 52. Turkey GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE GLP-1 Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of GLP-1 Injection by Type (2021–2032)
Figure 56. Global Revenue Market Share of GLP-1 Injection by Type (2021–2032)
Figure 57. Global GLP-1 Injection Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of GLP-1 Injection by Application (2021–2032)
Figure 59. Global Revenue Market Share of GLP-1 Injection by Application (2021–2032)
Figure 60. Global GLP-1 Injection Price (US$/Unit) by Application (2021–2032)
Figure 61. GLP-1 Injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
